Microsatellite instability and p53 mutations are associated with abnormal expression of the MSH2 gene in adult acute leukemia

Blood

Volumn 94, Issue 2, 1999, Pages 733-740

  Zhu, Y M ^b   Das Gupta, E P ^b   Russell, N H ^a  

^a NOTTINGHAM CITY HOSPITAL   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

ACUTE LEUKEMIA; ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DNA REPAIR; FEMALE; GENE DELETION; GENE EXPRESSION; GENE MUTATION; HETEROZYGOSITY; HUMAN; HUMAN CELL; MALE; MICROSATELLITE INSTABILITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

EID: 0033566355     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v94.2.733     Document Type: Article

References (41)

1. Modrich P, Lahue R: Mismatch repair in replication fidelity, genetic recombination, and cancer biology. Annu Rev Biochem 65:101, 1996.
2. Fishel R, Lescoe MK, Rao MRS, Copeland NG, Jenkins NA, Garber J, Kane M, Kolodner R: The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer. Cell 75:1027, 1993
3. Kolodner RD, Hall NR, Lipford J, Kane MR Rao MRS, Morrison P, Wirth L, Finan PJ, Burn J, Chapman P, Earabino C, Merchant E, Bishops DT: Structure of the human MSH2 locus and analysis of two Muir-Torre kindreds for MSH2 mutations. Genomics 24:516, 1994
4. Fishel R, Ewel A, Lescoe MK: Purified human MSH2 protein binds to DNA containing mismatched nucleotides. Cancer Res 54:5539, 1994
5. Fishel R, Ewel A, Lee S, Lescoe MK, Griffith J: Binding of mismatched microsatellite DNA sequences by the human MSH2 protein. Science 266:1403, 1994
6. Chung DC, Rustgi AK: DNA mismatch repair and cancer. Gastroenterology 109:1685, 1995
7. Ionov Y, Peinado MA, Malkbosyan S, Shibata D, Perucho M: Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinigenesis. Nature 363:558, 1993
8. Orth K, Hung J, Gazdar A, Bowcock A, Mathis JM, Sambrook J: Genetic instability in human ovarian cancer cell lines. Proc Natl Acad Sci USA 91:9495, 1994
9. Umar A, Boyer JC, Thomas DC, Nguyen DC, Risinger JI, Boyd J, Ionov Y, Perucho M, Kunkel TA: Defective mismatch repair in extracts of colorectal and endometrial cancer lines exhibiting microsatellite instability. J Biol Chem 269:14367, 1994
10. Wooster R, Cleton-Jansen A-M, Collins N, Mangion J, Cornelis RS, Cooper CS, Gusterson BA, Ponder BAJ, von Deimling A, Wiester OD, Cornelise CJ, Devilee P, Stratton MR: Instability of short tandem repeats (microsatellites) in human cancers. Nat Genet 6:152, 1994
11. Liu B, Parsons R, Hamilton SR, Peterson JM, Lynch HT, Watson P, Markowitz S, Willson JKV, Green J, de la Chapelle A, Kinzler K, Vogelstein B: hMSH2 mutations in hereditary nonpolyposis colorectal cancer kindreds. Cancer Res 54:4590, 1994
12. Liu B, Nicolaides NC, Markowitz S, Willson JKV, Parson RE, Jen J, Papadopolous N, Peltomaki P, de la Chapelle A, Hamilton SR, Kinzler K, Vogelstein B: Mismatch repair gene defects in sporadic colorectal cancers with microsatellite instability. Nat Genet 9:48, 1995
13. Boyer JC, Umar A, Risinger JI, Lipford JR, Kane M, Yin S, Barrett JC, Kolondner RD, Kunkel TA: Microsatellite instability, mismatch repair deficiency and genetic defects in human cancer cells. Cancer Res 56:4836, 1996
14. de Wind N, Dekker M, Berns A, Radman M, te Riele H: Inactivation of the mouse MSH2 gene in mismatch repair deficiency, methylation tolerance, hyperrecombination, and predisposition to cancer. Cell 82:321, 1995
15. Reitmair AH, Schmits R, Ewel A, Bapat B, Redston M, Mitri A, Waterhouse P, Mittrucker H-W, Wakeham A, Liu B, Thomason A, Griesser H, Gallinger S, Ballhausen WG, Fishel R, Mak TW: Msh2 deficient mice are viable and susceptible to lymphoid tumours. Nat Genet 11:64, 1995
16. Lane DP: p53: Guardian of the genome. Nature 358:15, 1992
17. Lowe SW, Schmitt EM, Smith GW, Osborne BA, Jacks T: p53 is required for radiation induced apoptosis in mouse thymocytes. Nature 362:846, 1993
18. Clarke AR, Purdie CA, Harrison DJ, Morris RG, Bird CC, Hooper ML, Wyllie AH: Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature 362:849, 1993
19. Lane DP, Benchimol S: p53: Oncogene or anti-oncogene? Gene Dev 4:1, 1990
20. Vogelstein B: Adeadly inheritance. Nature 348:681, 1990
21. Slingerland JM, Minden MD, Benchimol S: Mutation of the p53 gene in human acute myelogenous leukemia. Blood 77:1500, 1991
22. Fenaux P, Preudhomme C, Quiquandon I, Jonveaux P, Laï JL, Vanrumbeke M, Loucheux-Lefebvre MH, Bauters F, Berger R, Kerckaert JP: Mutations of the p53 gene in acute myeloid leukaemia. Br J Haematol 80:178, 1992
23. Hu G, Zhang W, Deisseroth AB: p53 gene mutations in acute myelogenous leukaemia. Br J Haematol 81:489, 1992
24. Wada M, Bartram CR, Nakamyra H, Hachiya M, Chen DL, Borenstein J, Mitter CW, Ludwig L, Hansen-Hagge TE, Ludwig WD: Analysis of p53 mutations in large series of lymphoid hematological malignancies of childhood. Blood 82:3163, 1993
25. Wattel E, Preudhomme C, Hecquet B, Vanrumbeke M, Quesnel B, Dervite I, Morel P, Fenaux P: P53 mutations are associated with resistance to chemotherapy and short survival in hematologic malignancies. Blood 84:3148, 1994
26. Hsiao MH, Yu AL, Yeargin J, Ku D, Haas M: Nonhereditary p53 mutations in T-cell acute lymphoblastic leukemia are associated with the relapse phase. Blood 83:2922, 1994
27. Diccianni MB, Yu J, Hsiao M, Mukherjee S, Shao LE, Yu AL: Clinical significance of p53 mutations in relapsed T-cell acute lymphoblastic leukemia. Blood 84:3105, 1994
28. Zhu Y-M, Foroni L, McQuaker IG, Papaioannou M, Haynes A, Russell N: Mechanisms of relapse in acute leukaemia: Involvement of p53 mutated subclones in disease progression in acute lymphoblastic leukaemia. Br J Cancer 79:1151, 1999
29. Ben-Yehuda D, Krichevsky S, Caspi O, Rund D, Polliak A, Abeliovich D, Zelig O, Yahalom V, Paltiel O, Reuven O, Peretz T, Ben-Neriah, Yehuda O, Rachmilewitz EA: Microsatellite instability and p53 mutations in therapy-related leukemia suggest a mutator phenotype. Blood 88:4296, 1996
30. Lowsky R, DeCoteau JF, Reitmair AH, Ichinohasama R, Dong WF, Xu Y, Mak TW, Kadin ME, Minden MD: Defects of the mismatch repair gene MSH2 are implicated in the development of murine and human lymphoblastic lymphomas and are associated with the aberrant expression of rhombotin-2 (Lmo-2) and TAL-1 (SCL). Blood 89:2276, 1997
31. Brimmell M, Mendiola, Mangion J, Packham G: Bax frameshift mutations in cell lines derived from human haemopoietic malignancies are associated with resistance to apoptosis and microsatellite instability. Oncogene 16:1803, 1998
32. Grimwade D, Walker H, Oliver F, Wheatley K, Harrison C, Harrison G, Rees J, Hann I, Stevens R, Burnett A, Goldstone A: The importance of diagnostic cytogenetics on outcome in AML: Analysis of 1,612 patients entered into the MRC AML 10 trial. Blood 92:2322, 1998
33. Meyers M, Theodosiou M, Acharya S, Odegaard E, Wilson T, Lewis JE, Davis TW, Van Patten CW, Fishel R, Boothman DA: Cell cycle regulation of the human DNA mismatch repair genes hMSH2, hMLH1, and hPMS2. Cancer Res 57:206, 1997
34. Marra G, Chang CL, Laghi LA, Chauhan DP, Young D, Boland CR: Expression of human Muts homolog-2 (hMSH2) protein in resting and proliferating cells. Oncogene 13:2189, 1996
35. Bubb VJ, Curtis LJ, Cunningham C, Dunlop MG, Carothers AD, Morris RG, White S, Bird CC, Wyllie AH: Microsatellite instability and the role of hMSH2 in sporadic colorectal cancer. Oncogene 12:2641, 1996
36. Lazar V, Grandjouan S, Bognel C, Couturier D, Rougier P, Bellet D, Bressac-de Paillerets B: Accumulation of multiple mutations in tumor-suppressor genes during colorectal tumorigenesis in HNPCC patients. Hum Mol Genet 3:2257, 1994
37. Borresen AL, Lothe RA, Meling GI, Lystad S, Morrison P, Lipford J, Kane MF, Rognum TO, Kolodner RD: Somatic mutations in the hMSH2 gene in microsatellite unstable colorectal carcinomas. Hum Mol Genet 4:2065, 1995
38. Percesepe A, Kristo P, Aaltonen L, de Leon MP, de la Chapelle A, Peltomaki P: Mismatch repair genes and mononucleotide tracts as mutations targets in coloreatal tumours with different degrees of microsatellite instability. Oncogene 17:157, 1998
39. Sill H, Goldman JM, Cross NCP: Rarity of microsatellite alterations in acute myeloid leukaemia. Br J Cancer 74:255, 1996
40. Tasaka T, Lee S, Spira S, Nagai M, Takahara J, Koeffler HP: Microsatellite instability during the progression of acute myelocytic leukaemia. Br J Haematol 98:219, 1997
41. Leith CP, Kopecky KJ, Godwin J, McConnell T, Slovak ML, Chen IM, Head DR, Appelbaum FR, Willman CL: Acute myeloid leukemia in the elderly: Assessment of multidrug resistance (MDR1) and cytogenetics distinguishes biologic subgroups with remarkably distinct responses to standard chemotherapy. A Southwest Oncology Group Study. Blood 89:3323, 1997